Theravance Biopharma
(NASDAQ:TBPH)
$9.71
0.25[2.64%]
At close: May 6
$9.71
0[0.00%]
After Hours: 4:55PM EDT
Q1 2024 Earnings in 6 days from now on Mon May 13th, after the market close
Conference call scheduled in 6 days at 17:00 PM Click to view the webcast

Theravance Biopharma Stock (NASDAQ:TBPH), Earnings Estimates, EPS, and Revenue

Theravance Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
May 13
EPS Estimate
$-0.250
Quarterly Revenue Estimate
$14M
Annual Revenue
(as of Dec 31)
$57.4M

Analyze the earnings history of Theravance Biopharma using advanced sorting and filters.

No data available to display
ticker
▲▼
Company Name
▲▼
Prior EPS
▲▼
Est EPS
▲▼
Actual EPS
▲▼
EPS Surprise
▲▼
Prior Rev
▲▼
Est Rev
▲▼
Actual Rev
▲▼
Rev Surprise
▲▼
Date
▲▼
Get Alert

FAQ

Q

When is Theravance Biopharma (NASDAQ:TBPH) reporting earnings?

A

Theravance Biopharma (TBPH) is scheduled to report earnings on August 5, 2024. The last reported earnings were for reported on February 26, 2024 for Q4.

Q

What were the latest earnings per share (EPS) for Theravance Biopharma (NASDAQ:TBPH)?

A

The Actual EPS was $-0.17, which missed the estimate of $-0.15.

Q

What were Theravance Biopharma’s (NASDAQ:TBPH) revenues?

A

The Actual Revenue was $17.6M, which missed the estimate of $17.7M.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch